Tvardi Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Tvardi Therapeutics, Inc.
Quantité totale PI 33
Rang # Quantité totale PI 44 056
Note d'activité PI 2,5/5.0    36
Rang # Activité PI 20 837
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

11 3
7 1
10 0
1
 
Dernier brevet 2025 - Stat3 inhibitors for use in the ...
Premier brevet 2019 - Stat3 inhibitors
Dernière marque 2022 - TVARDI
Première marque 2018 - TVARDI

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Stat3 inhibitors for use in the treatment of cancer. Provided herein, in some embodiments, are me...
2024 Invention Solid-state forms of stat3 inhibitors and methods of use thereof. Provided herein, in some embodi...
Invention Formulations of stat3 inhibitors and methods of use thereof. Provided herein are methods of treat...
Invention Prodrugs of stat3 inhibitors. Provided herein, in certain embodiments, are compounds of Formula ...
2023 Invention Stat3 inhibitors for use in the treatment of non-viral liver cancer. Provided herein, in some emb...
Invention Stat3 inhibitors. Compounds as STAT3 inhibitors are described. A pharmaceutical composition comp...
Invention Therapeutic compounds, formulations, and use thereof. The present disclosure, in part, is direct...
Invention Prodrugs of stat3 inhibitors. Provided herein, in certain embodiments, are compounds of Formula I...
Invention Therapeutic compounds, formulations, and use thereof. The present disclosure, in part, is directe...
Invention Therapeutic compounds, formulations, and use thereof
Invention Prodrugs of stat3 inhibitors. ((Formula I:) or a pharmaceutically acceptable salt or a solvate th...
Invention Prodrugs of stat3 inhibitors
Invention Combinations of stat-inhibitors and immune checkpoint inhibitors for the treatment and/or managem...
Invention Therapeutic compounds, formulations, and use thereof. Provided herein are solid amorphous disper...
Invention Therapeutic compounds, formulations, and use thereof. Provided herein are solid amorphous dispers...
2022 Invention Therapeutic compounds, formulations, and uses thereof. Provided herein are compositions, formulat...
P/S Pharmaceutical preparations for treating cancer, inflammation and fibrosis; pharmaceutical and th...
P/S Pharmaceutical research and development services
2021 P/S Pharmaceutical preparations for treating cancer, inflammation and fibrosis
2020 Invention Therapeutic compounds for methods of use in insulin resistance. Embodiments of the disclosure en...
Invention Therapeutic compounds for methods of use in insulin resistance. Embodiments of the disclosure enc...
Invention Stat3 inhibitors. Compounds as STAT3 inhibitors are described. A pharmaceutical composition compr...
2018 P/S Pharmaceutical preparations for treating cancer